PATENT CLAIM ANALYSIS

Application Number: 15882767
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "008100"]

Abstract:
The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.

Claim (Index 2):
The method of  claim 1 , wherein the epicardial progenitor cell selected for expression of epicardin, Nkx 2.5, Is1-1, GATA 5, WT1, Tbx18, and/or Tbx5 polypeptides or polynucleotides; has a biological activity selected from the group consisting of reducing cell death in a cell population at risk thereof, increasing cell survival, reducing inflammation, increasing epicardial cell proliferation, increasing epithelial to mesenchymal transformation, and increasing cardiac function; has a molecular weight that is at least about 5 kD; and is inactivated by heat denaturation.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 86.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13220555', '14826613', '14771747', '15623025', '15553505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8528335433281163
- 35 USC 102 Novelty (BERT): 0.6999933274929017
- Combined Prediction Score: 0.8375495217445948
- Mean Citation Score: 544.049848
- Max Citation Score: 818.1908
- Similarity Product: 713.5717957628249

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test